Report suggests US obesity epidemic may be improving - Scorecard - MDSpire

Report suggests US obesity epidemic may be improving

  • By

  • JoNel Aleccia

  • October 16, 2025

  • 0 min

Share

Clinical Scorecard: New Analysis Indicates Potential Improvement in US Obesity Rates

At a Glance

CategoryDetail
ConditionObesity (BMI ≥ 30) as a chronic disease linked to diabetes, stroke, cancer, and heart disease
Key MechanismsPotential drivers include appetite-suppressing drugs (e.g., Wegovy, Zepbound), nutrition assistance programs, and public health interventions
Target PopulationUS adults across all states and territories
Care SettingPublic health programs at federal, state, and local levels

Key Highlights

  • Number of states with obesity rates ≥35% decreased from 23 to 19 between 2023 and 2024, first decline in over a decade
  • No states showed statistically significant obesity rate increases or decreases in 2024 after prior years of increases
  • Federal funding cuts and program eliminations may threaten recent progress in obesity control

Guideline-Based Recommendations

Diagnosis

  • Define obesity as BMI ≥ 30 based on height and weight measurements

Management

  • Consider use of appetite-targeting medications such as Wegovy and Zepbound
  • Support nutrition assistance programs and promote physical activity
  • Implement multi-level public health interventions to improve nutrition and increase exercise

Monitoring & Follow-up

  • Utilize annual Behavioral Risk Factor Surveillance System telephone surveys to track obesity prevalence by state
  • Monitor state-level obesity rates for statistically significant changes over time

Risks

  • Obesity increases risk for diabetes, stroke, cancer, and heart disease
  • Cuts to federal staff and chronic disease programs may reverse progress

Patient & Prescribing Data

Adults with obesity in the United States

Increased use of appetite-suppressing drugs may contribute to recent improvements in obesity rates

Clinical Best Practices

  • Use BMI to identify and diagnose obesity in adults
  • Incorporate pharmacologic agents targeting appetite and digestion as appropriate
  • Enhance support for nutrition assistance and physical activity programs
  • Maintain and strengthen public health infrastructure to sustain obesity prevention efforts
  • Regularly analyze surveillance data to guide policy and intervention adjustments

References

Original Source(s)

Related Content